Mesenchymal Stem Cells: A Potential Border Patrol for Transplanted Islets?
Open Access
- 1 August 2009
- journal article
- editorial
- Published by American Diabetes Association in Diabetes
- Vol. 58 (8) , 1728-1729
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and -9Diabetes, 2009
- Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetesDiabetes & Metabolism, 2009
- Current status of islet cell transplantationJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- The Clinical Impact of Islet TransplantationAmerican Journal of Transplantation, 2008
- Transplantation: current developments and future directions; The future of clinical islet transplantation as a cure for diabetesFrontiers in Bioscience-Landmark, 2008
- New Reagents on the Horizon for Immune ToleranceAnnual Review of Medicine, 2007
- Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cellsExperimental Hematology, 2004
- Type 1 diabetes: new perspectives on disease pathogenesis and treatmentThe Lancet, 2001
- Human Marrow-Derived Mesenchymal Stem Cells (MSCs) Express Hematopoietic Cytokines and Support Long-Term Hematopoiesis When Differentiated Toward Stromal and Osteogenic LineagesJournal of Hematotherapy & Stem Cell Research, 2000
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999